Although we speculate that FOXA1 may regulate several important cellular processes in NSCLC cells independent of its interaction with GR, we elected to follow-up on this interaction given GR's known role in regulating key transcriptional programs relevant to cancer growth, progression, and therapeutic resistance (37–40) and the potential for therapeutic exploitation of GR. The gene discussed is FOXA1; the disease is cancer.